Literature DB >> 19183883

Protection against amyloid beta cytotoxicity by sulforaphane: role of the proteasome.

Hyun-Min Park1, Jung-Ae Kim, Mi-Kyoung Kwak.   

Abstract

The 26S proteasome plays a major role in degradation of abnormal proteins within the cell. The indirect antioxidant including sulforaphane (SFN) protects cells from oxidative damage by increasing the expression of Nrf2-target genes. It has been observed that the expression of multiple subunits of the proteasome was up-regulated by indirect antioxidants through the Nrf2 pathway. In the current study, the role of SFN in amyloid beta(1-42) (Abeta(1-42))-induced cytotoxicity has been investigated in murine neuroblastoma cells. Treatment with SFN protected cells from Abeta(1-42)-mediated cell death in Neuro2A and N1E 115 cells. Inhibition of proteasome activities by MG132 could abolish the protective effect of SFN against Abeta(1-42). Neuro2A cells, which were stably overexpressing the catalytic subunit of the proteasome PSMB5, showed an elevated resistance toward Abeta(1-42) toxicity compared to control cells. Furthermore, the in vitro assay demonstrated that the Abeta(1-42) peptide is degraded by the proteasome fraction. These results suggest that proteasome-inducing indirect antioxidants may facilitate the removal of the Abeta(1-42) peptide and lead to the amelioration of abnormal protein-associated etiologies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19183883     DOI: 10.1007/s12272-009-1124-2

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  21 in total

Review 1.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  On to the road to degradation: atherosclerosis and the proteasome.

Authors:  Joerg Herrmann; Lilach O Lerman; Amir Lerman
Journal:  Cardiovasc Res       Date:  2009-10-08       Impact factor: 10.787

Review 3.  Dysfunction of the ubiquitin-proteasome system in atherosclerotic cardiovascular disease.

Authors:  Feilong Wang; Amir Lerman; Joerg Herrmann
Journal:  Am J Cardiovasc Dis       Date:  2015-03-10

Review 4.  Sulforaphane - role in aging and neurodegeneration.

Authors:  Roberto Santín-Márquez; Adriana Alarcón-Aguilar; Norma Edith López-Diazguerrero; Niki Chondrogianni; Mina Königsberg
Journal:  Geroscience       Date:  2019-04-02       Impact factor: 7.713

5.  Transfusion of Old RBCs Induces Neuroinflammation and Cognitive Impairment.

Authors:  Hongying Tan; Jiangjiang Bi; Yunzhen Wang; Junfeng Zhang; Zhiyi Zuo
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

6.  Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological Aberrations.

Authors:  Marwa M Safar; Hany H Arab; Sherine M Rizk; Shohda A El-Maraghy
Journal:  Mol Neurobiol       Date:  2014-12-21       Impact factor: 5.590

7.  Genetic mechanisms of coffee extract protection in a Caenorhabditis elegans model of β-amyloid peptide toxicity.

Authors:  Vishantie Dostal; Christine M Roberts; Christopher D Link
Journal:  Genetics       Date:  2010-08-30       Impact factor: 4.562

8.  Activation of the stress proteome as a mechanism for small molecule therapeutics.

Authors:  Rebecca Deering Brose; Gloria Shin; Martina C McGuinness; Tonya Schneidereith; Shirley Purvis; Gao X Dong; Jeffrey Keefer; Forrest Spencer; Kirby D Smith
Journal:  Hum Mol Genet       Date:  2012-07-02       Impact factor: 6.150

9.  Sulforaphane Protects against Brain Diseases: Roles of Cytoprotective Enzymes.

Authors:  Y Sun; T Yang; L Mao; F Zhang
Journal:  Austin J Cerebrovasc Dis Stroke       Date:  2017-02-16

10.  Perspectives on the Clinical Development of NRF2-Targeting Drugs.

Authors:  Diego Lastra; Raquel Fernández-Ginés; Gina Manda; Antonio Cuadrado
Journal:  Handb Exp Pharmacol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.